Please assess the completion status of the following clinical trial:

Trial Title: A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Is obese with a body mass index (BMI) \>=30 kg/m\^2 to \<=50 kg/m\^2, and has been obese for at least one year before screening.~* Usually consumes at least three major meals (morning, midday, and evening) each day.~Exclusion Criteria:~* Is currently enrolled in a formal weight-loss program.~* Has had liposuction within 1 year before screening or is planning to have liposuction during the study.~* Has received any investigational drug within 3 months before screening.~* Has previously participated in a study using pramlintide.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Pramlintide Acetate (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).